Title:
医薬としてのアザインダゾールまたはジアザインダゾール型の誘導体
Document Type and Number:
Japanese Patent JP5931926
Kind Code:
B2
Abstract:
The present invention relates to a compound of following formula (I): or a pharmaceutically acceptable salt or solvate of same, a tautomer of same, or a stereoisomer or mixture of stereoisomers of same in any proportions, such as a mixture of enantiomers, notably a racemic mixture; as well as to the use of same as a drug, notably intended for the treatment of cancer, inflammation and neurodegenerative diseases such as Alzheimer's disease; to the use of same as a kinase inhibitor; to the pharmaceutical compositions comprising same; and to methods for the preparation of same.
Inventors:
Elle, Bashi, Karn
Karim, Bud Jegeral
Remi, lab
Anna, Curchinski
Philip, Schmidt
Michelle, Pele
Nicola and Laie
Karim, Bud Jegeral
Remi, lab
Anna, Curchinski
Philip, Schmidt
Michelle, Pele
Nicola and Laie
Application Number:
JP2013550886A
Publication Date:
June 08, 2016
Filing Date:
January 27, 2012
Export Citation:
Assignee:
Pierre, Fabre, Medicaman
International Classes:
C07D471/04; A61K31/437; A61K31/4545; A61K31/496; A61K31/4985; A61K45/00; A61P25/28; A61P29/00; A61P35/00; A61P43/00; C07D487/04
Domestic Patent References:
| JP2009506006A | ||||
| JP2008523018A | ||||
| JP2001516353A |
Foreign References:
| WO2003068773A1 |
Attorney, Agent or Firm:
Hirohito Katsunuma
Yukitaka Nakamura
Noritaka Yokota
Yukitaka Nakamura
Noritaka Yokota